bed...agree , the history makes development of an effective treatment look almost impossible, but ...(unless the results to date have been published to be intentionally misleading)...we are getting closer. So, we might ask the question of ourselves. What is the likelihood that results published to date were done to intentionally mislead investors? I say with confidence approaching certainty that the results were not intentionally misleading and that investors have interperated them correctly.
Imagine you are in a room full of shorts. Their task is to conduct a risk analysis of AVXL SP. The questions they have to answer is...(from a shorts point of view)...what could go wrong? What if it did, then what would happen? What is the likelihood of that happening?..... list of possibilities...1 A new patent or series f patents. 2. MJF adds to pot. 3. NIH gives $$$ for epilepsy. 4. Phase 2 results look great? 5. FDA grants BT status. TBI studies show promise with 2-73.6. BP partner for phase 3 trials.......Ok, OK, you get the idea. Huh, pretty risky way to live. Now you have to ask yourself. Do you feel lucky punk?
Won't a lot of the who gets attention/interest be determined by what happens between now and then? Dr M. is usually way out in front of this kind of thing. we'll see, not much time left. Else, the next conference.
If what you say is true then the competition is being screened out. The number of viable options is down...makes sense. have new product also with A 2-73 and viagra combo
Exactly, the likely sequence of events to unfold is unclear, but it won't be long.
Discoveries, AKA breakthroughs, jump off the page at whoever is doing the work. This would have been a galvanizing moment for those involved. Which is why (IMO) Dr M. is as driven and certain as he projects. It seems the AVXL team does not sweat the petty #$%$ we have all been agonizing ovrer, and they know why. Proving a theory is a beautiful thing. Small n notwithstanding , it is what it is. .......
People...excellent thread here...a positive learning experience for longs who read it...and a definite pucker experience for others. This is a long process though.
Great company, great employees , great airplane...well done
"Patent issuance will provide intellectual property protection in China for protein therapy, gene therapy and cell therapy applications of MANF"
Blockbuster yes, but also a technical breakthrough. The kind of change that grows explosively taking everything else around it with it(diagnostics, medicare, clinics, insurance co.s,) and we hope....lots of happier patients.